• Welcome Guest
  • View Cart
  • Phone (US): 703.778.3080
  • 0Shopping Cart
  • Market Reports
  • Market Research Subscriptions
    • Knowledge Center
  • Custom Market Research
    • Quantitative Market Research
    • Qualitative Market Research
    • RateMyProduct
  • Blog
  • Featured
    • Free Downloads
    • View Webinars On-Demand
    • The IVD Market in 2023: $130 Billion and Growing
    • The Point of Care Testing Market
    • Immunoassays
  • About Us
    • Contact
  • Search
  • Menu Menu
  • Biotechnology
    • Next Generation Sequencing
    • Proteomics
    • Biopharmaceuticals
    • Instrumentation & Equipment
    • Emerging Technologies
  • Pharmaceuticals
    • Vaccines
    • Drug Delivery
    • Over-the-Counter
    • Drug Discovery
    • Cancer Treatment
    • Manufacturing & Packaging
    • Prescription Drugs
  • Diagnostics
    • Molecular Assays
    • Point-of-Care
    • Immunoassays
    • Infectious Disease
    • Clinical Chemistry
    • Oncology & Hematology
    • Lab Testing Services
    • Medical Imaging
  • Healthcare
    • Information Technology
    • Facilities & Settings
    • Insurance & Managed Care
  • Medical Devices
    • Wound Care
    • Drug Delivery
    • Equipment
    • Surgical
  • Login
Awaiting product image

Filter your search

Search Report Keyword
Price
CATEGORIES
  • Biotechnology Market Research
  • cell and gene therapy
  • cell therapy
  • Diagnostics Market Research
  • gene therapy
  • Healthcare Information Technology
  • Healthcare Market Research
  • in vitro diagnostic
  • IVD
  • life sciences
  • Medical Devices Market Research
  • Molecular & Nucleic Acid Testing
  • Pharmaceuticals Market Research
  • Point-of-Care Diagnostics
  • sciences
  • vaccines

Knowledge Center Sidebar

Most Popular Research

  • Cell and Gene Therapy Business Outlook
  • The Worldwide Market for In Vitro Diagnostic Tests, 14th Edition
  • Clinical Diagnostics MasterFile
  • The Global Market for Medical Devices, 11th Edition
  • The World Market for Molecular Diagnostics Tests, 10th Edition
  • Remote Patient Monitoring and Telehealth Markets, 12th Edition

Inhaled Insulin: A Market Briefing

$895.00 – $1,790.00

Clear
SKU: KLI975906 Category: Medical Devices Market Research Pages: 56
  • Description
  • Table of Contents
  • Latest reports

Description

Alternative routes of administration for insulin has been one of the leading drivers of drug delivery industry. Although transdermal and transmucosal systems have shown promise and true oral delivery remains a goal, pulmonary delivery has emerged as the leading area of development.

Several major players in the pharmaceutical industry have given their backing to inhaled insulin projects, and product launches are imminent. However, the exact make-up of the market, patient acceptance, and regulatory progress are still not completely clear.

This market briefing analyzes the world markets for inhaled insulin technologies and products. This report focuses on the current and future markets for inhaled, or pulmonary, insulin delivery. The report generally reviews the nature and direction of research, as well as future markets. This briefing also profiles several companies involved in marketing or developing such products in the field, including Aerogen, Aradigm, Novo Nordisk and Pfizer.

Market forecasts are based on an examination of current market conditions and on investigations into the development of new products by key companies. Interviews were conducted with company executives, clinicians, researchers and public health officials. This information is also weighted with the projected timing and the probability of receiving FDA and other regulatory approval to market products. The information presented in this report is the result of data gathered from company product literature and other corporate brochures and documents, as well as information found in the scientific and trade press. Data gathered in the course of other major market studies from Kalorama Information are also presented where appropriate.

Table of Contents

Chapter One: Executive Summary

  • Current Insulin Delivery Methods
  • Pulmonary Delivery
  • Methodology
  • Market Trends
  • Summary of Findings

Chapter Two: Introduction

  • The Disease

    • Nature of Diabetes
    • Types of Diabetes
    • Complications
  • Incidence

    • An Epidemic
    • Related Complications
    • Geriatric Issues
  • New Approaches to Diabetes
  • Current Insulin Delivery Techniques

    • Syringes
    • Pens
    • Pumps
  • Modified Insulin Delivery

    • Pills
    • Skin Patches
    • Oral Sprays
  • Inhalation Systems

    • Demand and Acceptance
    • Issues

Chapter Three: The Market

  • Overall Market for Insulin
  • Market for Inhaler Systems
  • Competitive Landscape

Chapter Four: Key Players and Their Technologies

  • Alkermes Inc.
  • Aerogen Inc.
  • Aradigm Corp.
  • Aventis S.A.
  • Epic Therapeutics Inc.
  • Generex Biotechnology
  • Nektar Therapeutics
  • Novo Nordisk A/S
  • Pfizer Inc.

List of Exhibits

  • Exhibit 1: Prevalence of Diagnosed Diabetes by Age, US, 1980-2002
  • Exhibit 2: U.S. Prevalence of Type II Diabetes Cases by Age Group 45-54 years, 55-64 years, 65-74 years, and 75+ years 2003-2013
  • Exhibit 3: Number of new cases of diagnosed diabetes in people aged 20 years or older, by age group—United States, 2002
  • Exhibit 4: Total prevalence of diabetes in people aged 20 years or older, by age group—United States, 2002
  • Exhibit 5: Total Available U.S. Market Potential for Modified Delivery Insulin 2001-2010
  • Exhibit 6: Estimated Market for Insulin by Country (Top 7 World Markets) 2004-2008
  • Exhibit 7: Estimated World Market for Inhaled Insulin by Region 2004-2008
  • Exhibit 8: Status of Selected Inhaled Insulin Products in Development

 

    Global Market for Medical Devices, 14th Edition
    October 31, 2024
    Remote Patient Monitoring and Telehealth Markets, 13th Edition
    November 27, 2023
    The Global Market for Medical Devices, 13th Edition
    October 25, 2023
    The Market for Medical Devices, 12th Edition
    November 9, 2022

Related products

  • Placeholder image

    Wound Care Markets: Volume I: Skin Ulcers

    $1,875.00 – $3,750.00
  • Placeholder image

    The Worldwide Market For Dialysis Equipment, Supplies, and Services

    $3,500.00 – $7,000.00
  • Placeholder image

    Wound Care Markets, 2nd Edition, Vol I – Skin Ulcers

    $2,995.00 – $5,990.00
  • Placeholder image

    Diabetes in Germany: The Markets for Monitoring, Insulin, Oral Hypoglycemics, and Drugs to Treat Complications

    $371.00 – $742.00

Contact Us

  • 671 North Glebe Road, Suite 1610 Arlington, VA 22203 United States

  • Email Us

  • 703-778-3080

  • Send us a message!

Pay Invoice

  • Pay an Invoice by Credit Card

Follow Us!

Latest Blogs

  • 4 Fascinating Facts About Cancer Diagnostics March 4, 2025
  • Food Animal Diagnostics Market: Spotlight on Disease Testing Amid Bird Flu Surge February 20, 2025
  • Custom Competitive Intelligence (CI) Research: A New Strategic Imperative For Lab Diagnostics Companies  February 19, 2025
  • The Rise of Pharmacodiagnostics in the $10 Billion Global Cancer Diagnostics Market February 1, 2025
  • IVD Trends to Watch: Personalized Medicine Adds Precision to Diagnostic Testing January 2, 2025

Sitemap

  • Home
  • About
  • Blog
  • Contact
  • Sitemap

Your Data and Privacy

  • View our Privacy Policy
  • GDPR Statement
  • Privacy Settings

About Us

Kalorama Information, part of Science and Medicine Group, has been a leading publisher of market research in medical markets, including the biotechnology, diagnostics, medical device, and pharmaceutical industries for more than 30 years. Our comprehensive, timely, quality research and innovative approach to analysis and presentation of market intelligence have made Kalorama Information a premier source of market information for top industry decision makers.

Visit Science and Medicine Group
Monoclonal Antibodies in Cancer Therapy: Emerging Products and MarketsAmbulatory Infusion Pumps in Pain Management: A Market Briefing
Scroll to top